+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Ramipril"

ACE Inhibitors Global Market Report 2024 - Product Thumbnail Image

ACE Inhibitors Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
From
From
Ramipril (CAS 87333-19-5) Global Market Research Report 2024 - Product Thumbnail Image

Ramipril (CAS 87333-19-5) Global Market Research Report 2024

  • Report
  • April 2024
  • 50 Pages
  • Global
From
Hypertension Drugs Markets in China - Product Thumbnail Image

Hypertension Drugs Markets in China

  • Report
  • November 2023
  • 215 Pages
  • China
From
Hypertension Drugs Industry Forecasts - China Focus - Product Thumbnail Image

Hypertension Drugs Industry Forecasts - China Focus

  • Report
  • November 2023
  • 109 Pages
  • China
From
  • 9 Results (Page 1 of 1)
Loading Indicator

Ramipril is a drug used to treat cardiovascular diseases, such as hypertension, congestive heart failure, and myocardial infarction. It is an angiotensin-converting enzyme (ACE) inhibitor, which works by blocking the production of a hormone that causes blood vessels to narrow. This helps to reduce blood pressure and improve blood flow. Ramipril is also used to reduce the risk of stroke, heart attack, and death in people with coronary artery disease. It is available in both generic and brand-name formulations. Ramipril is a widely used drug in the cardiovascular market, with a long history of safety and efficacy. It is generally well-tolerated and has few side effects. It is also cost-effective, making it an attractive option for many patients. Some of the companies in the Ramipril market include Pfizer, Novartis, Merck, and Sanofi. Show Less Read more